“轻装上阵”谋转型上海医药拟转让中美施贵宝股权

经济参考报
Feb 11

上海医药(601607.SH)日前发布公告,公司拟通过产权交易所,以公开挂牌方式转让所持参股子公司中美上海施贵宝制药有限公司(简称“中美施贵宝”)30%股权,挂牌转让价格不低于10.23亿元,且需完成相关国有评估管理程序,最终转让价格以公开挂牌成交结果为准。  力争资产价值最大化  作为国内首批中外合资制药企业之一,中美施贵宝成立于1982年,由百时美施贵宝、中国医药对外贸易总公司和上海医药(集团...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10